CLASS II ONGOING Device recall · Reported 20 May 2026 · FDA Enforcement Report

Edwards Evoque tricuspid delivery system recalled

Edwards Lifesciences is recalling Edwards Evoque tricuspid delivery system, distributed nationwide in the US. The recall was initiated on 27 Mar 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Lots/UDI:0690103D004EVD000V5

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2172-2026
FDA event ID
98633
Recalling firm
Edwards Lifesciences, Irvine, CA
Classification
Class II
Status
Ongoing
Recall initiated
27 Mar 2026
FDA classified
13 May 2026
Reported
20 May 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Sterility

Timeline

27 Mar 2026Recall initiated by company
13 May 2026Classified by FDA+47 days
20 May 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling update to provide warning if functionality of the valve replacement delivery system is compromised.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Edwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EO

Where it was distributed

Worldwide - US Nationwide distribution including in the states of AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and the countries of Saudi Arabia, Germany, United Kingdom.

Nationwide ArkansasArizonaCaliforniaColoradoConnecticutDelawareFloridaGeorgiaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMaineMichiganMinnesotaMissouri

Questions about this recall

Is Edwards Evoque tricuspid delivery system recalled?

Yes. Edwards Lifesciences recalled Edwards Evoque tricuspid delivery system on 27 Mar 2026. The recall is Class II and its status is Ongoing. Recall number Z-2172-2026.

Why was it recalled?

Labeling update to provide warning if functionality of the valve replacement delivery system is compromised.

Which lots are affected?

All Lots/UDI:0690103D004EVD000V5

Where was it sold?

Worldwide - US Nationwide distribution including in the states of AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and the countries of Saudi Arabia, Germany, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Edwards Lifesciences

All 95

Other Other Medical Devices recalls

All 13,778